Clinical Practice of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Targeted Drugs Combined with Gadolinium Oxide Nanoparticles in the Treatment of Non-Small Cell Lung Cancer

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Oxide Nanoparticles ◽

Targeted Drugs ◽

Small Cell Lung ◽

Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients

European Journal of Cancer ◽

10.1016/j.ejca.2019.05.032 ◽

2019 ◽

Vol 117 ◽

pp. 107-115 ◽

Cited By ~ 7

Author(s):

Zong-Han Yao ◽

Wei-Yu Liao ◽

Chao-Chi Ho ◽

Kuan-Yu Chen ◽

Jin-Yuan Shih ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Inhibitor Treatment

125P Association of tumour CD4 positive lymphocytes with prognosis in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor

Annals of Oncology ◽

10.1016/j.annonc.2020.08.246 ◽

2020 ◽

Vol 31 ◽

pp. S290

Author(s):

Y-J. Zhu ◽

H-B. Zhang ◽

X-S. Chang ◽

Z-Z. Xiao ◽

L-R. Liu ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

A Comparative Study of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Treatment of Patients with Brain Metastasis from Non-Small Cell Lung Cancer

Annals of Oncology ◽

10.1016/s0923-7534(20)33879-5 ◽

2012 ◽

Vol 23 ◽

pp. ix421

Author(s):

L. Zhang ◽

L. Cai ◽

J. Zhu

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Brain Metastasis ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Dacomitinib, a second-generation irreversible epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) to treat non-small cell lung cancer

Drugs of Today ◽

10.1358/dot.2019.55.4.2965337 ◽

2019 ◽

Vol 55 (4) ◽

pp. 231 ◽

Cited By ~ 4

Author(s):

T. Nagano ◽

M. Tachihara ◽

Y. Nishimura

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Tki

Combination effects of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) and individual chemotherapeutics in non-small cell lung cancer (NSCLC) cells with and without sensitizing-EGFR mutations.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e18062 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e18062-e18062

Author(s):

C. Tsai ◽

K. Chang ◽

C. Chiu ◽

S. Hsiao

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Tki

Correlation between epidermal growth factor receptor tyrosine kinase inhibitor efficacy and circulating tumor cell levels in patients with advanced non-small cell lung cancer

OncoTargets and Therapy ◽

10.2147/ott.s115221 ◽

2016 ◽

Vol Volume 9 ◽

pp. 7515-7520 ◽

Cited By ~ 8

Author(s):

Wenjie He ◽

Wenhui Li ◽

Bo Jiang ◽

Li Chang ◽

Congguo Jin ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Circulating Tumor Cell ◽

Small Cell ◽

Small Cell Lung ◽

Antitumor activity of the epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) ZD1839 (‘lressa’), alone or combined with gemcitabine and vinorelbine platinum-based chemotherapy, in human non-small-cell lung cancer (NSCLC) xenografts

European Journal of Cancer ◽

10.1016/s0959-8049(02)80848-6 ◽

2002 ◽

Vol 38 ◽

pp. S62

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Platinum Based Chemotherapy ◽

Epidermal Growth ◽

Egfr Tki

Frequency of T790M mutations after progression on epidermal growth factor receptor tyrosine kinase inhibitor in metastatic non-small cell lung cancer in Indian patients: real-time data from tertiary cancer hospital

Lung India ◽

10.4103/lungindia.lungindia_451_17 ◽

2018 ◽

Vol 35 (5) ◽

pp. 390 ◽

Cited By ~ 5

Author(s):

VenkataPradeep Babu Koyyala ◽

Ullas Batra ◽

Parveen Jain ◽

Mansi Sharma ◽

Pankaj Goyal ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Time Data ◽

Real Time Data ◽

Ganetespib in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer

Anticancer Research ◽

10.21873/anticanres.13283 ◽

2019 ◽

Vol 39 (4) ◽

pp. 1767-1775 ◽

Cited By ~ 1

Author(s):

EISUKE KURIHARA ◽

KAZUHIKO SHIEN ◽

HIDEJIRO TORIGOE ◽

TATSUAKI TAKEDA ◽

YUTA TAKAHASHI ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment in Patients With EGFR Wild-Type Non–Small-Cell Lung Cancer: The Never-Ending Story

Journal of Clinical Oncology ◽

10.1200/jco.2013.50.2617 ◽

2013 ◽

Vol 31 (26) ◽

pp. 3291-3293 ◽

Cited By ~ 11

Author(s):

Francesco Gelsomino ◽

Francesco Agustoni ◽

Monica Niger ◽

Marika Valota ◽

Eva R. Haspinger

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Wild Type ◽

Small Cell Lung ◽

Epidermal Growth ◽

Inhibitor Treatment